期刊文献+

S100B水平与心功能及慢性心力衰竭的相关性研究 被引量:6

Correlation of the SIOOB level with cardiac function and chronic heart failure
原文传递
导出
摘要 目的探讨S100B水平与心功能及慢性心力衰竭(心衰)的相关性。方法选择80例老年心衰患者为心衰组,同时选择同期健康体检者80例为对照组。确定心衰组纽约心脏病协会(NYHA)心功能分级。比较两组S100B、NT—proBNP水平,左心室舒张末内径(LVEDD)和左心室射血分数(LVEF)。分析S100B与NT-proBNP、LVEF及NYHA心功能分级水平的相关性。结果心衰组S100B(91.4±31.9)pg/L较对照组(74.9±26.0)pg/L水平升高(t=1.980,P=0.000)。NT-proBNP及LVEDD水平升高,LVEF水平降低,差异有统计学意义(均P〈0.01)。S100B水平与NT-proBNP呈正相关(r=0.309,P=0.003);与NYHA分级呈正相关(r=0.508,P=0.001);与LVEF呈负相关,差异有统计学意义(r=-0.192,P:0.004)。结论S100B蛋白水平在慢性心衰患者中明显升高,且与患者心功能呈负相关,对于心衰诊断和评估的有提示意义,但仍需更多的循征依据。 Objective To investigate the correlation of the S100B level with cardiac function and chronic heart failure. Methods A total of 80 elderly chronic heart failure (CHF) patients who accepted treatments in our hospital from March 2012 to December 2013 were recruited, and 80 subjects undergoing health examinations served as the control group. The New York Heart Association (NYHA) functional classification in the experimental group was determined. Serum levels of S100B and NT-proBNP, left ventricular end diastolic diameter (LVEDD) and left ventricular ejection fraction (LVEF) were compared between the groups, and the correlation of the S100B level with NT-proBNP, LVEF and the NYHA functional classification were analyzed. Results The serum S100B level was increased in the experimental group as compared with the control group [(91.4 ±31.9) pg/L w (74.9±26.0) pg/L, t=1.980, P=0.000]. The serum NT-proBNP level was higher, LVEDD was longer, and LVEF was lower in the experimental group than in the control group (all P〈0.01). The serum S100B level was positively correlated with NT-proBNP (r=0. 309, P= 0. 003) and the NYHA functional classification ( r= 0. 508, P= 0. 001), and negatively correlated with the LVEF (r=-0. 192, P=0. 004). Conclusions The serum S100B level is increased in patients with CHF and negatively correlated with cardiac function, suggesting that the S100B protein may serve as a valuable tool for the diagnosis and assessment of CHF. However, more studies are needed to provide more evidence.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2015年第5期491-493,共3页 Chinese Journal of Geriatrics
关键词 心力衰竭 S100蛋白质类 利钠肽 Heart failure S100 proteins Natriuretic peptide, brain
  • 相关文献

参考文献9

  • 1冯惠芳,陈小平,冯涛,等.帕罗西汀对老年慢性心力衰竭合并焦虑患者心功能和血浆脑钠肽的影响[J].中华老年医学杂志,2014,33:641—642.
  • 2Kamimura D, Ohtani T, Sakata Y, et al. Ca2+ entry mode of Na+/Ca2+ exchanger as a new therapeutic target for heart failure with preserved ejection fraction[J]. Euro Heart J, 2012, 33 ~1408-1416.
  • 3Cai XY, Lu L, Wang YN, et al. Association of increased S100B, S100A6 and S100P in serum levels with acute coronary syndrome and also with the severity of myocardial infarction in cardiac tissue of rat models with isehemia-reperfusion injury [J]. Atherosclerosis, 2011, 217 ~ 536 542.
  • 4陈琦玲,刘梅颜,胡大一.老年心力衰竭患者血浆脑钠肽与N末端B型钠尿肽影响因素的探讨[J].中华老年医学杂志,2010,29(1):27-29. 被引量:21
  • 5Duda T, Pertzev A, Sharma, RK, et al. Differential CJ+ sensor guanylate cyclase activating protein modes of photoreceptor rod outer segment membrane guanylate cyclase signaling[J]. Biochemistry, 2012, 51:4650-4657.
  • 6Miki Y, Gion Y, Mukae Y, et al. Morphologic, flow cytometric, functional, and molecular analyses of S100B positive lymphocytes, unique cytotoxic lymphocytes containing S100B protei[J~. Euro J Haematol, 2013, 90..99-110.
  • 7张勇,唐海沁,李瑾.老年慢性心力衰竭患者血浆B型利钠肽与糖类抗原125水平的变化[J].中华老年医学杂志,2013,32(5):473-475. 被引量:21
  • 8Kitazawa M, Cheng D, Tsukamoto MR, et al. Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal beta-catenin pathway function in an Alzheimer's disease model[J]. J Immunol, 2011, 187..6539-6549.
  • 9Mohammadzadeh K, Desjardins F, Tsoporis J, et al. S100B.. role in eardiae remodeling and function following myocardial infarction in diabetes[J]. Life Sci, 2013, 92:639-647.

二级参考文献22

  • 1Lainchbury JG,Lisy O, Burnett JC Jr, et al. Actions of a novel synthetic natriuretic peptide on hemodynamics and ventricular function in the dog. Am J Physiol Regul Integr Comp Physiol, 2002, 282: R993-R998.
  • 2Kjaer A,Hsesse B. Heart failure and neuroendocrine activation:diagnostic and therapeutic perspectives. Clin Physiol,2001,21:661-672.
  • 3Tsutamoto T,Wada A,Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventrieular dysfunction. Circulation. 1997.96:509-516.
  • 4LainchburyJG, Nicholls MG, Espiner EA, et al. Regional plasma levels of cardiac peptides and their response to acute neutral endopeptidase inhibition in man. Clin Sci (Lond), 1998,95: 547-555.
  • 5Richards AM,Crozier IG, Yandle TG, et al. Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease. Br Heart J,1993,69:414-417.
  • 6Schou M, Dalsgaard MK, Clemmesen O, et al. Kidneys extract BNP and NT proBNP in healthy young men. J Appl Physiol,2005,99:1676-1680.
  • 7Johns DG, Ao Z, Heidrich BJ, et al. Dendroaspis natriuretic peptide binds to the natriuretic peptide clearance receptor. Biochem Biophys Res Commun, 2007,358:145-149.
  • 8Jian ZJ. Etiology and diagnosis of heart failure in theelderly patients. Chin J Geriatr, 2005, 2:156-158.
  • 9Weber M, Hamm C. Role of B-type natriuretie peptide (BNP) and NT proBNP in clinical routine. Heart, 2006, 92:843-849.
  • 10D'Aloia A,Faggiano P, Aurigemma G, et al. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis. J Am Coil Cardiol, 2003, 41:1805-1811.

共引文献41

同被引文献56

引证文献6

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部